Mosaic ImmunoEngineering (CPMV) Interest Coverage Ratio (2010 - 2026)
Mosaic ImmunoEngineering (CPMV) posted quarterly Interest Coverage Ratio of 62.75 for Q1 2026, up 11.46% year-over-year from 56.3 in Q1 2025, and down 9.58% quarter-over-quarter from 57.26 in Q3 2025.
Mosaic ImmunoEngineering (CPMV) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Mosaic ImmunoEngineering's Interest Coverage Ratio history runs 11 years deep, the most recent figure standing at 62.75 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 11.46% year-over-year to 62.75; the TTM figure through Mar 2026 stood at 79.69 (down 16.61% YoY), while the FY2025 annual figure was 0.17, up 30.91% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 62.75, down from 57.26 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 24.16 in Q4 2024, with the low at 70.87 in Q1 2025.
- The 3-year median for Interest Coverage Ratio is 61.23 (2026), against an average of 56.82.
- The sharpest annual moves came in 2025 and 2026: Interest Coverage Ratio climbed 13.48% in 2025, then advanced 11.46% in 2026.
- Mosaic ImmunoEngineering's Interest Coverage Ratio stood at 24.16 in 2024, then slumped by 136.97% to 57.26 in 2025, then dropped by 9.58% to 62.75 in 2026.
- Business Quant data shows CPMV's Interest Coverage Ratio at 62.75 in Q1 2026, 57.26 in Q3 2025, and 59.71 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | Mosaic ImmunoEngineering | 527,536.97 | 527,536.97 | - | -62.75 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -62.75 |
| Sep 30, 2025 | -57.26 |
| Jun 30, 2025 | -59.71 |
| Mar 31, 2025 | -70.87 |
| Dec 31, 2024 | -24.16 |
| Sep 30, 2024 | -66.18 |
| May 31, 2019 | 1.10 |
| May 31, 2018 | 0.92 |
| Aug 31, 2015 | -2.64 |
| Nov 30, 2014 | -3.21 |
| Aug 31, 2014 | -0.48 |
| May 31, 2014 | -7.05 |
| Nov 30, 2013 | 1.12 |
| Aug 31, 2013 | 0.13 |
| May 31, 2013 | 3.19 |
| Feb 28, 2013 | -0.15 |
| Nov 30, 2012 | 2.18 |
| Aug 31, 2012 | 0.29 |
| May 31, 2012 | -1.39 |
| Feb 29, 2012 | 0.74 |